SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-017213
Filing Date
2019-05-08
Accepted
2019-05-08 16:16:25
Documents
45
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q1-2019 evok-10q_20190331.htm 10-Q 855813
2 EX-10.1 evok-ex101_436.htm EX-10.1 312315
3 EX-10.2 evok-ex102_437.htm EX-10.2 19716
4 EX-31.1 evok-ex311_8.htm EX-31.1 9583
5 EX-31.2 evok-ex312_9.htm EX-31.2 9865
6 EX-32.1 evok-ex321_6.htm EX-32.1 5034
7 EX-32.2 evok-ex322_7.htm EX-32.2 5253
  Complete submission text file 0001564590-19-017213.txt   2813052

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT evok-20190331.xml EX-101.INS 355073
9 XBRL TAXONOMY EXTENSION SCHEMA evok-20190331.xsd EX-101.SCH 29628
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE evok-20190331_cal.xml EX-101.CAL 16393
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE evok-20190331_def.xml EX-101.DEF 72249
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE evok-20190331_lab.xml EX-101.LAB 185499
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE evok-20190331_pre.xml EX-101.PRE 138583
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36075 | Film No.: 19806808
SIC: 2834 Pharmaceutical Preparations